Dr. Voelker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Lilly Corporate Ctr
Indianapolis, IN 46285Phone+1 317-277-7590Fax+1 317-433-6661
Summary
- James Voelker, MD, is a nephrologist based in Indianapolis, IN. He graduated from Indiana University School of Medicine in 1981 followed by a Internal Medicine residency at the Medical College of Virginia, nephrology fellowship training at University of Texas Health Southwestern Medical Center, and a fellowship in Clinical Pharmacology at UTSMC and IUMC. His published work includes research on diabetic nephropathy, pharmacokinetics, and novel clinical biomarkers, with notable publications like "Anti-TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy" cited 178 times.
Education & Training
- Indiana University School of MedicineFellowship, Clinical Pharmacology, 1986 - 1987
- Indiana University School of MedicineClass of 1981
Certifications & Licensure
- IN State Medical License 1981 - 2025
- TX State Medical License 1985 - 1992
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 1 citationsEstimating the distribution of a novel clinical biomarker (FGF-23) in the US population using findings from a regional research registryJoseph A. Johnston, David R. Nelson, Limin Zhang, Sarah E Curtis, James Voelker
Plos One. 2019-06-27 - 176 citationsAnti-TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy.James Voelker, Paul Berg, Matthew J. Sheetz, Kevin L. Duffin, Tong Shen
Journal of the American Society of Nephrology. 2017-03-01 - 9 citationsPharmacokinetics and safety of single doses of tabalumab in subjects with rheumatoid arthritis or systemic lupus erythematosusJennifer Witcher, Roy Fleischmann, Vishala Chindalore, Ryan John Hansen, Leijun Hu
British Journal of Clinical Pharmacology. 2016-02-25
Grant Support
- Effect Of Renal Dysfunction On The Pharmacokinetics Of EfegatranNational Center For Research Resources1996
- Desmopressin In Normal Volunteers--Relationship Of ETS Current DensityNational Center For Research Resources1996
- Captopril And Angiotensin Vascular Effects In SenescenceNational Center For Research Resources1995
- Age Effects On Arterial Endothelium Derived Nitric Oxide Vasodilator SystemNational Center For Research Resources1995
- Captopril And Angiotensin Vascular Effects In SenescenceNational Institute On Aging1991–1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: